Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coffee Consumption and Oxidative DNA Damage, Apoptosis and Collagen Synthesis in HCV-related Liver Disease: a Prospective Randomized Trial.

NCT01572103 is registered in ClinicalTrials.gov with Azienda Ospedaliera di Padova as lead sponsor.

NCT NCT01572103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01572103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coffee Consumption and Oxidative DNA Damage, Apoptosis and Collagen Synthesis in HCV-related Liver Disease: a Prospective Randomized Trial.
Lead sponsor
Azienda Ospedaliera di Padova
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2010
Completion date
June 30, 2011
Enrollment
40 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hcv-related hepatitis